Muscle and Liver Insulin Resistance Indexes Derived From the Oral Glucose Tolerance Test
暂无分享,去创建一个
[1] R. Rabasa-Lhoret,et al. Muscle and Liver Insulin Resistance Indexes Derived From the Oral Glucose Tolerance Test , 2007, Diabetes Care.
[2] S. Haffner,et al. The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. , 2006, The American journal of cardiology.
[3] E. Ford,et al. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. , 2005, Diabetes care.
[4] S. Blair,et al. Cardiorespiratory fitness and body mass index as predictors of cardiovascular disease mortality among men with diabetes. , 2005, Archives of internal medicine.
[5] E. Ford. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. , 2005, Diabetes care.
[6] S. Fowler,et al. The Effect of Metformin and Intensive Lifestyle Intervention on the Metabolic Syndrome: The Diabetes Prevention Program Randomized Trial , 2005, Annals of Internal Medicine.
[7] T. Buchanan,et al. Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women. , 2002, Diabetes.
[8] S. Fowler,et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002, The New England journal of medicine.
[9] T. Valle,et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. , 2001, The New England journal of medicine.
[10] D A Follmann,et al. The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Quantitative Insulin Sensitivity Check Index: A Simple, Accurate Method for Assessing Insulin Sensitivity In Humans , 2022 .
[11] M. Stumvoll,et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. , 2000, Diabetes care.
[12] M. Matsuda,et al. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. , 1999, Diabetes care.
[13] M. Stumvoll,et al. Renal glucose production and utilization: new aspects in humans , 1997, Diabetologia.
[14] R. DeFronzo. The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM , 1988, Diabetes.
[15] R. Turner,et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.
[16] R. DeFronzo,et al. The Disposal of an Oral Glucose Load in Healthy Subjects: A Quantitative Study , 1985, Diabetes.
[17] R. DeFronzo,et al. Regulation of Splanchnic and Peripheral Glucose Uptake by Insulin and Hyperglycemia in Man , 1983, Diabetes.
[18] R. DeFronzo,et al. Hepatic and peripheral insulin resistance: A common feature of Type 2 (non-insulin-dependent) and Type 1 (insulin-dependent) diabetes mellitus , 1982, Diabetologia.
[19] N. Abumrad,et al. Absorption and disposition of a glucose load in the conscious dog. , 1982, The American journal of physiology.
[20] R. DeFronzo,et al. The Effect of Insulin on the Disposal of Intravenous Glucose: Results from Indirect Calorimetry and Hepatic and Femoral Venous Catheterization , 1981, Diabetes.
[21] R. DeFronzo,et al. Glucose clamp technique: a method for quantifying insulin secretion and resistance. , 1979, The American journal of physiology.
[22] R. DeFronzo,et al. The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents. , 1992, Diabetes.
[23] L. Groop,et al. Role of free fatty acids and insulin in determining free fatty acid and lipid oxidation in man. , 1991, The Journal of clinical investigation.